For example, previous studies reported that LINC-PINT levels in plasma are lower in pancreatic cancer patients than healthy controls [42,51], and that LINC-PINT suppresses the growth of pancreatic cancer cells through TGF-β pathway activation [51], which suggests that LINC-PINT can be a diagnostic and a prognostic biomarker of pancreatic cancer. Here, LINC-PINT is linked to pancreatic neoplasm.